Client:
Halma International Limited
Represented Halma International Limited, the leading safety, health, and sensor technology group, in the acquisition of 100% shares of the Swiss corporation Medicel AG, together with its subsidiary Robutec GmbH. Dinsmore attorneys prepared and negotiated the Share Purchase Agreement and related closing documents. These related acquisitions required dual-track due diligence and negotiation of all transactional documents. Related to the Medicel acquisition was negotiation of tax-planning documentation for a U.K.-based investor. The purchase, valued at $100,000,000, further extended the client’s presence in the ophthalmic surgical instrument market.